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Abstract
Rationale Various occupational groups are required to main-
tain optimal physical and cognitive function during overnight
periods of wakefulness, often with less than optimal sleep.
Strategies are required to help mitigate the impairments in
cognitive function to help sustain workplace safety and
productivity.
Objectives To test the effectiveness of repeated 200 mg doses
of caffeine on cognitive function and live-fire marksmanship
with soldiers during three successive nights of sustained
wakefulness followed by 4-h afternoon sleep periods.
Methods Twenty Special Forces personnel (28.6±4.7 years,
177.6±7.5 cm and 81.2±8.0 kg) were randomly assigned to
receive four 200-mg doses of caffeine (n=10) or placebo (n=
10) during the late evening and early morning hours during
three successive days. An afternoon 4-h sleep period follow-
ed. The psychomotor (PVT) and field (FVT) vigilance, logical
reasoning (LRT) tests and a vigilance monitor assessed
cognitive function throughout the study. Live-fire marksman-
ship requiring friend–foe discrimination was assessed.
Results Caffeine maintained speed on the PVT (p<0.02),
improved detection of events during FVT (p<0.001), in-
creased number of correct responses to stimuli as assessed
by the vigilance monitor (p<0.001) and increased response
speed during the LRT (p<0.001) throughout the three over-
night testing periods. Live-fire marksmanship was not altered
by caffeine.
Conclusions A total daily dose of 800 mg caffeine during
successive overnight periods of wakefulness is an effective
strategy to maintain cognitive function when optimal sleep
periods during the day are not available.
Keywords Sleep loss . Sustained operations . Afternoon
sleep . Cognitive function .Marksmanship
Introduction
Many occupational groups, such as shift workers, long-haul
truck drivers, emergency responders and deployed military
personnel, must maintain optimal cognitive and physical per-
formance over several consecutive days; often, this occurs
with inadequate sleep opportunities provided at non-optimal
periods during the day. Under these conditions, strategies to
counter the impairments in cognitive function that accompany
sleep loss (Belenky et al. 2003; Lieberman et al. 2002, 2005;
Thomas et al. 2000) are needed to help sustain workplace
safety and productivity. Furthermore, appropriate countermea-
sures need to be developed based on both controlled labora-
tory and field experimentation.
Caffeine (1,3,7 trimethylxanthine) is the most widely con-
sumed psychoactive substance in the world (Barone and Rob-
erts 1996). When consumed, it is absorbed and distributed
throughout the body, including the brain, and exerts its
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influence as an adenosine A1 and A2A receptor antagonist (for
reviews, see Carvey et al. 2012; Fredholm et al. 1999). Caf-
feine has significant effects on arousal of rested individuals
(Lieberman et al. 1987; Smith et al. 1999; Warburton 1995)
and substantial positive effects on vigilance, alertness and
mood during periods of sleep loss (Kamimori et al. 2000,
2005; Lieberman et al. 2002). A relatively high 600-mg dose
of caffeine is as effective as prescription medications such as
modafinil and amphetamines for improving cognitive func-
tion and countering sleep loss during periods of prolonged
wakefulness (Wesensten et al. 2002, 2004, 2005a). Daily
consumption of caffeine is considered safe and without
long-term risk for healthy adults (Bordeaux and Lieberman
2013; Higdon and Frei 2006; Nawrot et al. 2003). Thus,
caffeine is a viable candidate to sustain productivity and safety
in the workplace during periods of extended operations that
restrict sleep.
Military operations are an occupational setting where sol-
diers can be required to maintain periods of prolonged wake-
fulness, which can lead to extensive decrements in cognitive
function (Belenky et al. 1994; Lieberman et al. 2005).
Lieberman et al. (2002) studied the ability of caffeine to
maintain cognitive function during a stressful military training
exercise, which involved more than 3 days of sleep restriction
together with physical and mental challenges. Following 72 h
of sleep deprivation, a 200- and 300-mg dose of caffeine
improved several measures of cognitive function including
vigilance, reaction time, attention and mood, as well as im-
proving speed of target acquisition during marksmanship
testing compared with placebo (Lieberman et al. 2002;
Tharion et al. 2003). A subsequent series of studies collec-
tively demonstrated that a total dose of 600 mg caffeine
provided throughout a night without sleep was effective in
maintaining vigilance during both simulated urban and field
observational tasks (McLellan et al. 2005a, b), restoring or
improving physical performance compared with the rested
state (McLellan et al. 2004, 2005b), as well as improving or
maintaining marksmanship (McLellan et al. 2005a; Tikuisis
et al. 2004).
Although caffeine’s positive effects on vigilance and arous-
al during periods of sustained wakefulness have been repeat-
edly demonstrated (Beaumont et al. 2001; Bonnet et al. 1995;
Kamimori et al. 2005; Lieberman et al. 2002; McLellan et al.
2005a, b), the effect of the drug on higher level cognitive
function, such as executive control of attention and working
memory, during periods of sleep deprivation appears less
consistent (Wesensten et al. 2005a). Cognitive demands in a
military workplace often require making complex decisions
and responding and adapting to novel situations. Thus, to
demonstrate caffeine’s effectiveness in such an occupational
setting, it is necessary to assess the efficacy of caffeine on
more complex tasks, in addition to tests of vigilance and
reaction time.
Furthermore, restricting sleep periods to the daytime over
several days is a scenario consistent with current military
engagements and demands of other occupations that require
shift work. Often, these daytime sleep periods are not of suffi-
cient duration or may not provide sleep of optimal quality
(Torsvall et al. 1989). Thus, it is not known whether these work
conditions might increase the need to use a counter-measure
strategy, such as caffeine, to help sustain cognitive function.
Previous studies that have assessed the use of caffeine and
afternoon sleep periods have used the afternoon sleep as a
preventative measure prior to a period of overnight sustained
wakefulness (Bonnet and Arand 1994b; Bonnet et al. 1995;
Schweitzer et al. 2006). The authors are unaware of studies that
have compared the effectiveness of recovery afternoon sleep
periods on performance with or without caffeine during subse-
quent overnight periods of sustained wakefulness.
The purpose of this study was to examine the effectiveness
of repeated administration of 200 mg doses of caffeine to
sustain vigilance, reaction time, higher-order cognitive func-
tion that requires logical reasoning and live-fire marksman-
ship during three successive evenings of sustained wakeful-
ness followed by 4-h afternoon periods for sleep. Caffeine was
delivered in gum form since it is absorbed more rapidly into
the circulation, presumably through the buccal tissue, than
caffeine ingested in pill form (Kamimori et al. 2002). Further-
more, this mode of delivery was chosen to be consistent with
our previous studies that assessed the physical and cognitive
effects of caffeine during sustained military operations con-
ducted overnight (McLellan et al. 2005a, b). It was
hypothesised that the cognitive function and marksmanship
of participants receiving caffeine would be enhanced com-
pared to those receiving placebo, despite the opportunity for
all volunteers to sleep during the afternoon periods.
Methods
Participants
This study was approved by the human ethics review com-
mittees of Walter Reed Army Institute of Research USA,
Defence R&D Canada–Toronto, the New Zealand Northern
Region and the New Zealand Defence Force. Volunteers were
not enrolled if they were taking any medication or if they had
given blood within 30 days of the study. Twenty male Special
Forces personnel aged 28.6±4.7 years (mean±SD), with
height of 177.6±7.5 cm and body mass of 81.2±8.0 kg par-
ticipated in this study. All were cleared to participate in the
study by their base Medical Officer. An initial briefing in-
formed potential volunteers of the details, discomforts and
risks associated with the experimental protocol, and written
informed consent was obtained. After the briefing, soldiers
were assigned randomly into five groups of four with two
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soldiers in each group receiving caffeine (total n=10) or
placebo (total n=10) in a double-blind manner. The soldiers
were informed that no coffee- or caffeine-containing products
were to be consumed after awakening on the morning of day 1
of the study. The limited number of volunteers precluded
inclusion of additional caffeine and placebo groups that would
not be given the opportunity for daytime sleep. However,
since current military operational scenarios provide limited
sleep opportunities during the day, the current study was
designed to be of the greatest ecological validity for the end-
user.
Caffeine questionnaire
A questionnaire was administered to determine average daily
caffeine consumption. This questionnaire collected informa-
tion regarding the type and volume of caffeinated beverages
consumed daily, such as coffee, tea, soft drinks and energy
drinks, daily consumption of chocolate bars and candies and
the use of caffeinated over-the-counter medications. The cal-
culated average caffeine use for each individual was used to
examine the relationship between caffeine use and field vigi-
lance test (FVT) performance.
Caffeine and placebo
Caffeine or placebo was administered at 2145, 0100, 0345 and
0700 h beginning the evening of day 2 and continuing through
the morning of day 5 (Table 1). Two pieces of 100-mg caffeine
gum (Stay Alert®, Marketright Inc., Plano, IL) or placebo
were chewed for 5 min for a total dose of 800 mg caffeine
over a 24-h period. This total overnight dose of 800 mg
caffeine was greater than used during previous studies that
examined a single overnight period of sustained wakefulness
and testing (McLellan et al. 2005a, b). However, this repeated
200 mg dose of caffeine at 2–3-h intervals is effective for
sustaining elevated plasma caffeine levels and maintaining
cognitive performance throughout a night of sleep loss
(Kamimori et al. 2005; Syed et al. 2005). In addition, the last
200 mg dose in the morning was provided in close proximity
to the performance of an obstacle course. Both the placebo
and caffeine gum contained sugar, gum base, corn syrup,
natural and artificial flavours, fructose, glycerine, sucralose,
Table 1 The timeline for the study design
Day Time (h) Task
One 0745 Participant briefing and initial training on
cognitive tasks
0815 Control live-fire and familiarization of obstacle
course
2000 Familiarization of cognitive tasks
2030 Control FVT
2230 Familiarization of cognitive tasks
Two 0800 Control obstacle course
0900 Control cognitive tasks
1815 PVT, LRT
2100 PVT, LRT
2145 200 mg drug or placebo, PVT
2200 Live-fire marksmanship followed by PVT
Three 0045 PVT, LRT
0100 200 mg drug or placebo, PVT
0130 FVT session 1
0330 PVT, LRT
0345 200 mg drug or placebo, PVT
0415 FVT session 2
0615 PVT, LRT
0700 200 mg drug or placebo, PVT
0730 Obstacle course
1300 PVT followed by 4-h sleep period
1815 PVT, LRT
2100 PVT, LRT
2145 200 mg drug or placebo, PVT
2200 Live-fire marksmanship followed by PVT
Four 0045 PVT, LRT
0100 200 mg drug or placebo, PVT
0130 FVT session 3
0330 PVT, LRT
0345 200 mg drug or placebo, PVT
0415 FVT session 4
0615 PVT, LRT
0700 200 mg drug or placebo, PVT
0730 Obstacle course
1300 PVT followed by 4-h sleep period
1815 PVT, LRT
2100 PVT, LRT
2145 200 mg drug or placebo, PVT
2200 Live-fire marksmanship followed by PVT
Five 0045 PVT, LRT
0100 200 mg drug or placebo, PVT
0130 FVT session 5
0330 PVT, LRT
0345 200 mg drug or placebo, PVT
0415 FVT session 6
0615 PVT, LRT
0700 200 mg drug or placebo, PVT
Table 1 (continued)
Day Time (h) Task
0730 Obstacle course
0920 PVT followed by 2-h sleep period
1130 PVT, de-brief and release
Cognitive tasks included logical reasoning (LRT), psychomotor vigilance
(PVT) and the field vigilance (FVT) tests
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artificial colour and butylated hydroxytoluene and were sim-
ilar in appearance and taste.
Study design
The study timeline is presented in Table 1. After reporting for
duty on the morning of day 1, participants were familiarised
with the cognitive tasks and monitor, which included the
psychomotor vigilance test (PVT), the logical reasoning test
(LRT) and the wrist-worn vigilance monitor, described below.
They also performed a familiarization trial on the obstacle
course and control live-fire marksmanship testing. Results
from the obstacle course are provided elsewhere (McLellan
et al. 2007). After conducting regular training exercises for the
remainder of the day, additional practice on the cognitive test
battery and control testing for the FVTwere conducted in the
evening. A normal 8-h period of sleep was provided overnight
between days 1 and 2.
After reporting for duty on the morning of day 2, soldiers
performed control baseline testing for the obstacle course and
the cognitive tasks. Regular military training was conducted
for the remainder of the day. The experimental period began
after an evening meal. Participants were tested through the
evening of day 2 and morning of day 3 and did not have an
opportunity for sleep until 1330 hrs on day 3 for a 4-h period
(Table 1). Participants repeated the same testing throughout
the evening of day 3 and morning of day 4 and were provided
with another 4-h period for sleep at 1330 h of day 4. Regular
meals were provided throughout, and participants conducted
their normal training when their time was not occupied by
experimental procedures. Testing was again repeated through-
out the evening of day 4 and morning of day 5, with the trial
ending at 1130 h on the morning of day 5 when participants
were de-briefed and released (Table 1).
Psychomotor vigilance test (PVT)
The PVT was administered on Handspring Palm Platinum
personal digital assistants (PDAs) running Palm operating
system 3.1. The PVT is a test of continuous vigilance (Dinges
and Powell 1985). The test presents a visual cue (a bull’s-eye)
that appears in the middle of a screen. The subject’s task is to
press a designated key as soon as possible after the visual cue
appears. The time between each presentation of the cue is
randomised to between 1 and 5 s with a total of 85 stimuli
presentations per test session. Performance is recorded on a
minute-by-minute basis. Variables measured include reaction
time, and the number of minor (a reaction time>500 ms<
3000 ms) and major lapses (a reaction time≥3000 ms) before
responding to the cue. Speed is presented as the inverse of
reaction time.
Logical reasoning test (LRT)
The LRT was administered on Sony Clie PDAs using Palm
operating system 5.0. This test is an adaptation of a pencil and
paper linguistic task requiring knowledge of English grammar
and syntax (Baddeley 1968) and the ability to determine
whether various simple sentences correctly describe the rela-
tional order of two symbols. On each trial, the symbol pair “#
&” or “& #” is displayed along with a statement directly under
it that correctly or incorrectly describes the order of the sym-
bols as depicted in the example below:
& #
# is first
The participant must decide as quickly as possible whether
the statement is true or false and then press the corresponding
response button. There were 32 statements presented. Depen-
dent measures included the number correct and average cor-
rect mean response time (seconds).
Vigilance monitor
The vigilance monitor is a lightweight (48 g) ambulatory
monitoring system (VIGMON II, Precision Control Devices,
Inc., Fort Walton Beach, FL), slightly larger than a wristwatch
(3.8×3.8×1.2 cm) worn on the non-dominant wrist. The
monitor continually assesses a variety of behavioural and
environmental factors, such as temperature, humidity and
sleep/wake cycles (Lieberman and Coffey 1997). Volunteers
were instructed to respond to a sequence of up to three
vibrating stimuli, similar to the vibration of a pager or mobile
phone, during the 2-h FVT test sessions. During these inter-
vals, the stimuli were presented randomly every 5 to 20 min,
with an average inter-stimulus interval of 15 min. The volun-
teer was instructed to push a small button on the monitor in
response to the stimulus.
Each sequence of stimuli provided up to three opportu-
nities to respond. Once a subject responded, no additional
stimuli were presented until the next sequence occurred. If
the subject did not respond to the first stimulus in the
sequence (lasting 120 ms, 40 % max vibration) within 6 s,
a second slightly longer (160 ms) and more intense stimulus
(50 % max) was presented, and the subject had another 6 s
to respond. If he still failed to respond a third and final
longer (240 ms) and more intense (60 % max) stimulus was
presented and the subject had eight additional seconds to
respond. If the subject responded to any of the stimuli in a
sequence, it was recorded as a “hit.” If the subject did not
respond at all, it was recorded as a “miss.” Data were
analyzed as correct responses and latency to respond from
the first stimulus offset.
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Actigraphy
Volunteers wore an actigraph (Octagonal Sleep Watch, Preci-
sion Control Design, Ft Walton beach, FL) on their non-
dominant arm for 7 days prior to and throughout the study.
The actigraph is a device approximately the size of a diving
watch and records arm movement. Actigraphy records were
downloaded to a computer and scored as either “sleep” or
“wake” using an algorithm developed at the Walter Reed
Army Institute of Research.
Field vigilance test (FVT)
Details of this test have been provided previously (McLellan
et al. 2005b). Briefly, participants assumed a seated or prone
position 4–5 m apart, 175–200 m away from a building façade
illuminated by interior and exterior lights. This façade was
used regularly for the participants’ normal night vigilance
training, and, as a result, they were familiar with the nomen-
clature used to identify windows, doors and floors on the
building. The participants were required to record where,
when and what of any activity that occurred in and around
this building over a 120-min observational period. Within
each 20-min block, one activity that lasted approximately 5 s
was randomly presented. Each activity was awarded a maxi-
mum of 3 points, one for recording the appropriate time of the
activity, one point for describing the activity accurately and a
third point if the volunteer stated accurately where the activity
occurred. The total possible points awarded for this activity
was 18.
After each FVT session, participants were asked to record
the amount of time they felt they were asleep. They were
asked to place a mark on a scale delineated into 15-min blocks
from 0 to 120 min.
Live-fire marksmanship test
This live-fire room-clearing exercise consisted of three sce-
narios designed to evaluate friend–foe identification effective-
ness under time pressure. Participants had to accurately dis-
tinguish cardboard picture targets of friends (hostages) from
foes (terrorists). Dependent variables included the percentage
of friends and foes correctly targeted during a trial.
Statistical analyses
The data were analysed with an analysis of variance with one
grouping factor (drug or placebo) and repeated factors for time
represented as days and testing sessions within each day. All
analyses were conducted using SPSS (version 15.0; SPSS
Inc., Chicago, IL, U.S.A.). To correct for the violation of the
sphericity assumption with the repeated factor, a Huynh-Feldt
correction (Lyman 1993) was applied to the F-ratio. When a
significant F-ratio was obtained, a least significant difference
post hoc analysis was used to isolate differences among treat-
ment means. Pearson-product correlational analyses were per-
formed for both groups separately to determine the relation-
ship between their history of caffeine use and changes from
control scores in FVT performance during each overnight
period throughout the trial. An average FVT score was deter-
mined during each night of testing and subtracted from the
control value. For all statistical analyses, the 0.05 level of
significance was applied. Values are presented as mean±stan-
dard error of the mean.
Results
Analysis of the caffeine-use questionnaire indicated that
two participants receiving caffeine and three receiving
placebo were nonusers of caffeine. For the remaining par-
ticipants, routine caffeine consumption varied from a low
of 5 to a high of 410 mg day−1. Average daily caffeine
consumption was not significantly different between the
caffeine (86.9±27.1 mg day−1) and placebo (170.7±
43.3 mg day−1) groups. Although the mean values were
not different, the placebo group had five low consumers of
caffeine (less than 50 mg day−1) and two higher consumers
(410 and 290 mg day−1), whereas the caffeine group had
six low consumers and only one higher consumer
(225 mg day−1).
Wrist monitors and sleep patterns
On the evening immediately preceding the study, there was no
difference between treatment groups in total sleep time
(p>0.05) assessed by wrist monitors. There was a significant
main effect for group for the amount of sleep recorded during
the afternoons on days 3 and 4, and the morning of day 5.
Participants receiving caffeine (64.6±16.8 min) slept signifi-
cantly less than those receiving placebo (115.3±15.0 min)
during all three sleep opportunities.
Since participants remained essentially motionless for the
duration of the FVTsessions, the wrist monitors were not able
to discern sleep periods from times of minimal motion. As a
result, these data are not presented. There was a main effect of
group and session for self-reported sleep during the FVT, but
no other effects or interactions were observed. The placebo
group reported significantly more sleep (62.4±7.2 min) than
the caffeine group (19.8±7.2 min) throughout each overnight
FVT, and both groups reported less sleep during FVT session
1 (37.8±4.8 min) than FVT session 2 (44.4±5.4 min) each
night.
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Psychomotor vigilance test (PVT)
There was a significant main effect for time (p<0.001) and a
significant group×time interaction (p<0.02) for PVT. Partic-
ipants in both groups were significantly slower on the PVT
during the overnight testing beginning at 0045 until 0700 h
compared with testing earlier in the evening. As shown in
Fig. 1, there was no difference in PVT between groups at the
beginning of each evening of testing. However, those receiv-
ing caffeine were significantly faster on the PVT than placebo
at 0100, 0345 and 0615 h across days 3, 4 and 5.
There was no difference between groups in minor or major
lapses on PVT. Participants in both groups had more major
lapses at 0350 h on day 3 (0.35±0.11) than at any other time or
day.
Field vigilance test (FVT)
Preliminary findings from this test have been described pre-
viously (McLellan et al. 2007). Details of the control and
overnight FVT scores are presented in Fig. 2. There was no
difference between groups during the control testing but the
caffeine group scored significantly more points (p<0.001)
than those receiving placebo throughout the three nights of
restricted sleep (10.8±1.4 versus 6.1±0.8 points for caffeine
and placebo, respectively). Both groups performed signifi-
cantly worse (p<0.001) during the second night of testing
(6.9±1.1) compared with night 1 (9.8±1.5) and night 3 (8.7
±1.4), but no interactions were observed.
Vigilance monitor
Overall, there was a main effect of the caffeine (p<0.001)
where the number of correct stimuli responses for participants
receiving caffeine (7.6±0.4) was significantly greater than
those receiving placebo (4.8±0.3). Figure 3 displays the num-
ber of correct responses over the test sessions. Post hoc
analyses of the significant group×session interaction
(p<0.01) revealed that group responses were equal during
control testing, but differences were observed between groups
during sessions 2, 3, 5 and 6.
Logical reasoning test (LRT)
Figure 4 presents the mean correct response reaction times
over the test sessions. There was a main effect of group
(p<0.001) indicating that overall the caffeine group correctly
responded more rapidly (1.9±0.07 s) than placebo (2.5±
0.07 s). Post hoc analyses indicated there were no differences
between groups at the beginning of each overnight period of
testing. However, significant differences between groups were
observed during the overnight trials at 0330 and 0615 h on
days 3 and 4, and during 0615 h on Day 5 (p<0.05).
There was a significant effect of treatment for the number
of correct responses. Overall, participants in the placebo group
made more correct responses (31.0±0.2) than those receiving
caffeine (30.0±1.3). Post hoc analyses, however, did not
reveal significant differences between groups at any of the
test sessions.
Live-fire marksmanship
Three participants were excluded from these analyses due to
their lack of experience in marksmanship compared with the
other volunteers. The caffeine and placebo groups consisted of
nine and eight participants, respectively. There was no effect
of treatment or interaction of treatment and test day on the
percentage of foes correctly targeted. Similarly, there was no
effect of treatment group or an interaction of treatment and test
day on the percentage of friends correctly targeted.
Relationship of history of caffeine use to overnight FVT
There was no relationship between history of caffeine use and
performance during FVTcompared with control scores during
the overnight testing on day 3 (r=−0.01), day 4 (r=0.02) or
day 5 (r=0.01) for those who received caffeine. Correlations
were also non-significant for the placebo group, but values
were moderately positive, indicating some relationship be-
tween a larger decrease in performance during FVT with
greater daily caffeine use (r=0.61, 0.46 and 0.32 for days 3,
4 and 5, respectively). However, these data were skewed by
the one participant with the highest daily reported caffeine use
of 410 mg. When their data were excluded, correlations again
were non-significant and actually negative (r=−0.15, −0.12
and −0.60 for days 3, 4 and 5, respectively) suggesting that
performance for those participants with higher daily caffeine
use deteriorated less over the three nights. History of caffeine
use was also not related to self-reported hours of sleep during
FVT for participants in either group.
Discussion
Cognitive performance
This study demonstrates the effectiveness of caffeine as a
countermeasure to offset impairments in cognitive function
that accompany successive days of reduced sleep. In military
theatres of operations, adverse changes in cognitive function
are associated with increased friendly-fire incidents (Belenky
et al. 1994), and in the transportation industry, these impair-
ments are related to an increase in accidents (Horne and Reyner
1995). Importantly, this study suggests that the use of caffeine
could sustain workplace productivity and safety in
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occupational settings that provide less than optimal periods of
sleep during successive days of operations and require person-
nel to function during the overnight hours.
The impact of sleep loss on cognitive function is well
documented (Dinges and Kribbs 1991; Kreuger 1989;
Lieberman et al. 2002; Thomas et al. 2000), and the magni-
tude of these effects can be equal to or greater than the
impairments associated with moderate levels of alcohol intox-
ication, clinical doses of sedating drugs or clinical
hypoglycaemia (Lieberman et al. 2005). It was evident in this
study that under such adverse circumstances reaction time
slowed, vigilance decreased and speed of decision-making
was reduced. This supports the general recommendation of
optimising sleep behaviour in occupations where these cog-
nitive components are important for ensuring safety in the
workplace.
The benefits of using caffeine as a countermeasure to offset
cognitive impairments during a period of sustained wakeful-
ness are well established (Beaumont et al. 2001; Kamimori
et al. 2000, 2005; Lieberman et al. 2002; Penetar et al. 1993;
Walsh et al. 1990; Wesensten et al. 2005a). In a military
setting, caffeine is also effective in maintaining vigilance
and reaction time during periods of sleep deprivation
(Lieberman et al. 2002; McLellan et al. 2005a, b), as well as
restoring or improving physical performance (McLellan et al.
2004, 2005b, 2007) and maintaining or improving marksman-
ship (McLellan et al. 2005a; Tharion et al. 2003; Tikuisis et al.
2004). The findings from the current investigation extend
these previous observations on the repeated use of caffeine
during successive overnight periods of sustained operations
with restricted opportunities for sleep.
Cognitive performance during the first overnight period of
sustained wakefulness in the late evening of day 2 and early
morning of day 3 was maintained with repeated 200-mg doses
of caffeine as demonstrated by significant performance
Fig. 1 Response speed during
the psychomotor vigilance test
beginning during the evening of
day 2 through to the morning of
day 5 for the caffeine and placebo
groups. The asterisk indicates a
significant group by time
interaction over the 3 days. The
arrows indicate when 200 mg of
caffeine or placebo was
administered
Fig. 2 The number of points recorded during the control (CTRL) and six
field vigilance test (FVT) sessions for the caffeine and placebo groups.
The asterisk indicates a significant main effect between groups through-
out the overnight testing sessions, whereas the cross indicates that both
groups performed worse during the second night of testing
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improvements in PVT, FVTand LRT compared with placebo.
These differences between caffeine and placebo are consistent
with our previous field studies that examined the effects of
caffeine during a single overnight period of sleep loss
(McLellan et al. 2005a, b). In addition, the current study
demonstrated that subsequent 4-h sleep opportunities during
the afternoon were not able to restore the impairments in
cognitive function that followed the overnight periods of
sustained wakefulness without caffeine supplementation.
Those receiving placebo slept more during the overnight
vigilance testing as well as during the afternoon sleep periods,
yet their cognitive performance remained significantly im-
paired compared with those receiving caffeine. Despite
obtaining less sleep during the afternoon periods, the soldiers’
Fig. 3 The number of correct
responses to the stimuli presented
on the vigilance monitor during
the control (CTRL) and six field
vigilance test (FVT) sessions for
the caffeine and placebo groups.
The asterisk indicates a
significant difference between
groups during the given test
session
Fig. 4 Mean correct response
time during the logical reasoning
test beginning during the evening
of day 2 through to themorning of
day 5 for the caffeine and placebo
groups. The asterisk indicates a
significant difference between
groups during the given test
session
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cognitive performance improved with continued overnight
caffeine supplementation and was comparable with baseline
scores, with the exception of some reductions during the
second overnight testing period.
It cannot be determined whether afternoon sleep periods
assisted in maintaining cognitive performance for those re-
ceiving caffeine since our experimental design did not include
a group that was required to remain awake for the duration of
the study. Other studies that have included afternoon sleep
periods prior to overnight sleep deprivation and compared the
effectiveness of caffeine supplementation on cognitive func-
tion during the overnight period have used the prior sleep
periods as a preventative measure (Bonnet and Arand 1994a;
b; Bonnet et al. 1995; Schweitzer et al. 2006), rather than for
the purpose of restoration following sleep loss as was per-
formed in the current investigation. Many studies that have
examined the effectiveness of caffeine alone to enhance cog-
nitive performance during sleep loss have either tested the
effect during a single overnight period of sustained wakeful-
ness (Kamimori et al. 2005; McLellan et al. 2005a, b; Walsh
et al. 1990) or did not provide the caffeine until a longer period
(40 h or more) of sleep loss had elapsed (Kamimori et al.
2000; Lieberman et al. 2002; Penetar et al. 1993; Wesensten
et al. 2002, 2004, 2005a). Thus, direct comparisons to the
current investigation are not possible. However, during 48 h of
sleep deprivation, it has been reported that repeated 300 mg
doses of caffeine every 6 h beginning early during the first
overnight period could not sustain cognitive performance at
baseline levels during the second night of sleep loss (Bonnet
et al. 1995). Similarly, although cognitive performance of the
caffeine-treated group improved versus the placebo-treated
group throughout 64 h of sustained wakefulness with twice
daily doses of 300 mg slow release caffeine, performance
began to deteriorate relative to baseline scores during the
second overnight period of sleep loss (Beaumont et al.
2001). In the present study, there were also some decrements
in cognitive performance for FVT during the second overnight
period, but this was not the case for LRT, PVTor responses to
the vigilance monitor and the FVT responses rebounded to
baseline levels during the third night of testing. Thus, it
appears that the additional sleep during the afternoon, albeit
only 65 min as indicated by wrist monitors, was an effective
strategy together with the repeated dosing of caffeine (total,
800 mg/night) during the overnight periods to sustain cogni-
tive performance for the duration of the current study.
Interestingly, the combination of caffeine together with
afternoon sleep periods maintained higher-order decision-
making at baseline levels for the duration of the study. These
effects are most clearly illustrated in Fig. 4 where the over-
night circadian effect is demonstrated by the prolonged
decision-making latencies during the LRT for the placebo
group but not for those receiving caffeine. The positive impact
of caffeine on decision-making processes has been
demonstrated during the initial 24 h of sleep loss (Bonnet
and Arand 1994b; Bonnet et al. 1995), but the effects become
either less consistent (Wesensten et al. 2005a) or become
similar to placebo with longer periods of sleep deprivation
(Bonnet et al. 1995). Thus, in the present study, the additional
afternoon sleep periods and/or the higher total dose of caffeine
during the overnight periods may have accounted for the
extended benefits that were observed during the LRT. Exper-
imental design for future study would ideally include a group
that was required to remain awake for the duration of the study
in order to conclusively determine whether afternoon sleep
periods assisted in maintaining cognitive performance for
those receiving caffeine.
Occupational circumstances in the civilian workplace
would generally be less extreme than the sleep-loss scenario
examined in the current study, as the former might include
additional nights of sustained wakefulness but longer recovery
sleep periods during the day. Nevertheless, it has been shown
that reducing daily sleep from 9 h to 5 or 7 h over a 7-day
period produces persistent reductions in cognitive function
during the day. The sustained impairment in cognitive func-
tion for the placebo group in the current study is consistent
with these reductions in cognitive performance observed over
this 7-day period of chronic sleep restriction (Belenky et al.
2003). Use of a countermeasure strategy, such as caffeine,
would seem necessary to restore cognitive function, even in
these less severe occupational settings, as long as the daytime
recovery sleep periods are less than optimal. However, one
might expect that the caffeine dose required to restore cogni-
tive performance to baseline levels would be less than the
cumulative dose of 800 mg used in the current investigation.
It should also be noted that continued overnight dosing of
caffeine could compromise and/or reduce the duration and
quality of the limited sleep opportunities that exist during
the day. If quality of sleep is reduced, then performance
benefits from caffeine could be reduced during subsequent
overnight periods of sustained wakefulness. Studies that have
assessed the impact of caffeine on quality of sleep have
typically administered the drug during a period of sustained
wakefulness (from 24 to 64 h), which was followed by a
single recovery sleep period during the day (Beaumont et al.
2005; Carrier et al. 2007, 2009; Killgore et al. 2008; LaJambe
et al. 2005; Wesensten et al. 2005b). Interestingly, those
studies that assessed cognitive function following this recov-
ery sleep period reported little, if any, impairment due to
reduced quality of sleep following caffeine ingestion (Beau-
mont et al. 2005; Killgore et al. 2008; LaJambe et al. 2005;
Wesensten et al. 2005b). However, none of these studies
continued to assess cognitive performance during subsequent
overnight periods of sleep loss that included caffeine inges-
tion, with additional recovery sleep periods provided during
the day. In the present study, despite receiving less sleep
during the afternoon recovery sleep periods (as indicated by
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actigraphy) the caffeine group continued to perform better
during the overnight periods of sustained wakefulness. Thus,
at least for the scenario of three successive overnights ses-
sions, caffeine was a successful countermeasure strategy to
sustain cognitive function despite the reduced duration of
afternoon sleep.We cannot state for certain whether continued
redosing with caffeine during additional overnight periods of
sleep loss would continue to sustain cognitive performance
despite potentially less recovery sleep. Also, with continued
overnight dosing, a tolerance to caffeine may develop, which
could reduce the effects of a given dose of the drug on
cognitive function.
Marksmanship
Accurate targeting of friend and foe is a skill requiring both
fine motor control and higher-order decision-making capabil-
ity. It has been reported that live-fire accuracy was impaired
with sleep loss yet maintained with an overnight total caffeine
dose of 600 mg when conventional forces personnel were
tested (McLellan et al. 2005a). In addition, with highly trained
Special Forces personnel, neither sleep loss nor ingestion of a
cumulative 600-mg dose of caffeine affected live-fire marks-
manship (McLellan et al. 2005b). In the current investigation,
accurate live-fire decisions of friend and foe targeting were
unchanged compared with placebo conditions over cumula-
tive sleep loss. It is critical that caffeine not impair marksman-
ship if it is to be used in military settings where accurate
marksmanship is essential. Fine motor control and hand
steadiness may be reduced following ingestion of larger caf-
feine doses approximating 400 mg (Jacobson et al. 1991), and
these changes might be expected to impact marksmanship
accuracy. In this study, when testing followed the initial
200 mg dose of caffeine provided in the late evening on each
day, accuracy was unchanged. It is not known whether testing
conducted following the overnight periods of sleep loss that
accompanied total caffeine doses of 800 mg, (approximately
10 mg kg−1) would have led to impairments in marksmanship.
Although we did not directly assess hand steadiness, collec-
tively, the findings suggest that caffeine will not have detri-
mental effects on live-fire marksmanship for highly trained
military personnel. This observation is consistent with studies
that assessed marksmanship with small arms simulators
(Tharion et al. 2003; Tikuisis et al. 2004) rather than using
live-fire, friend–foe testing scenarios.
Limitations
There were certain study limitations that could affect the inter-
pretation of our findings. First, experimental control is reduced
during field experimentation, and access to study participants
and time constraints negated options for inclusion of caffeine or
placebo study groups who did not receive afternoon sleep
periods. Nonetheless, the ecological validity of the study design,
which included input of the end-user, is an important consider-
ation with field experimentation, and reduced experimental con-
trol may be one limitation that cannot be fully addressed.
Second, outcome measures for cognitive tests such as the
PVT and LRT involve speed or time. It has been suggested
that caffeine can have a direct effect on nerve conduction
velocity (Bazzucchi et al. 2011), which could account for
some of the changes observed for the caffeine group with
these dependent measures. In contrast, others have not ob-
served an increase in motor unit firing rates following caffeine
ingestion (Kalmar and Cafarelli 1999; Meyers and Cafarelli
2005; Plaskett and Cafarelli 2001), and these findings are
consistent with our view that caffeine impacts cognitive func-
tion, as assessed by tests such as the PVTand LRT, through its
antagonistic effects on central adenosine receptors rather than
through a direct effect on nerve conduction velocity. Never-
theless, the reader should remain cognizant of the fact that
caffeine’s effects on peripheral motor responses may influence
outcome measures of tests designed to assess cognitive
function.
Also, it has been suggested that caffeine’s positive effects
on arousal and vigilance reflect primarily the reversal of
withdrawal effects imposed by abstinence periods within
study designs (James 1994; James et al. 2005; Rogers 2014).
However, other investigators have disputed this hypothesis
(Einöther and Giesbrecht 2013; Lieberman et al. 2002). In the
present study, the abstinence period was almost 48 h prior to
the first drug administration; thus, withdrawal effects, if pres-
ent, should have begun to decrease (Juliano and Griffiths
2004). In addition, the majority of participants would be
considered light or non-habitual consumers of caffeine where
withdrawal effects would be minimal or non-existent (Rogers
et al. 2013). Also, except for the one participant with the
highest reported daily caffeine use, correlations between
changes in performance during FVT over successive nights
of testing and habitual caffeine use were weak and non-sig-
nificant. Finally, the data were reanalyzed with the highest
consumers of caffeine removed from both groups, and the
main effect of the drug and the interaction effects remained as
stated in the results. Interestingly, when only the low con-
sumers (less than 50 mg day−1) were compared for the caf-
feine (n=6) and placebo (n=5) groups, the FVT still revealed
an effect of the drug and a decrease in performance for the
placebo group on nights 2 and 3, whereas the caffeine group’s
performance remained unchanged. As a result, it is unlikely
that withdrawal reversal was responsible for the differential
effects observed between the drug and placebo groups.
The LRT demonstrated significant effect in which the pla-
cebo group made more correct responses, but overall the caf-
feine group correctly responded more rapidly. This suggests
speed/efficiency of processing was improved with caffeine. In
theMarksmanship test, response timewas notmeasured; hence,
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it is not known whether placebo treated personal took longer to
identify and accurately respond to the friend–foe stimuli
resulting in the unchanged results in both groups for targeting.
Finally, cognitive function is known to exhibit a circadian
rhythm (Monk et al. 1997), and the control FVT scores were
obtained at a time where cognitive performance would be
expected to be better than performance in the early morning
hours. Thus, in addition to the effects of sleep loss, some of the
deterioration in performance observed among the placebo
group could reflect this circadian effect, which was also evi-
dent during the LRT (see Fig. 4). Nonetheless, caffeine was
able to maintain performance during FVT comparable to the
control condition throughout the overnight period of testing
(see Fig. 2), and the drug removed any evidence of a circadian
effect on the response to the LRT (see Fig. 4).
Conclusion
This study demonstrates that 800 mg of caffeine provided
during overnight periods of wakefulness is an effective strategy
to sustain cognitive function when less than optimal sleep
periods are provided during the afternoon. Reaction time, vig-
ilance and logical reasoning were all maintained with caffeine
supplementation and remained at or close to control levels for
the duration of the study. Thus, when individuals are required to
work during the overnight and do not receive sufficient sleep
during the day, caffeine supplementation at night should be
considered to help maintain workplace productivity and safety.
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